RXO, Inc. (RXO)

NYSEIndustrialsTruckingSnapshot 2026-10-23

$28.75-0.59%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge RXO, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+5.0%

+10% or more+5%0%−5%−10% or less

0.62 → 0.65 EPS · FY ending Dec 31, 2027 · 12 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 12 to 12; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
EBITDA	$35M–$45Mnon-GAAP	—
FY 2026 · Q4
Revenue	—	1.83B
EPS	—	0.098
FY 2026 · Annual
Revenue	—	6.85B
EPS	—	0.142
FY 2027 · Annual
Revenue	—	7.55B
EPS	—	0.652

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
EPS turns positive and grows	A supporting condition in RXO, Inc.'s published investment case. The stated target is EPS >= $0.07 in FY2026 and >= $0.51 in FY2027.	Improving	EPS falls below $0.07 in FY2026 or below $0.51 in FY2027	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Gross margin holds near 13-15%	A supporting condition in RXO, Inc.'s published investment case. The stated target is Gross margin >= 12% next fiscal year.	Intact	Gross margin falls below 12% in FY2025	Gross margin: 14.04% FY2026-Q2; GAAP. Published target: Gross margin >= 12% next fiscal year. Target period is not explicitly aligned with this observation. Source published Aug 6, 202614.036077 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Operating income improves toward break-even	RXO is improving its operating income, reducing losses from -$30M to -$28M in Q1 2026.	Improving	Operating income falls below -$28M next 4 quarters	Operating income: $1M FY2026-Q2; GAAP. Published target: Operating income >= -$28M in next 4 quarters. Target period is not explicitly aligned with this observation. Source published Aug 6, 20261,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: feab9039-cf2a-4cbf-8ed8-75f32ab32229. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue grows beyond $1.4 billion per quarter	The company aims to grow revenue beyond $1.4 billion per quarter.	Intact	Revenue falls below $1.425B per quarter next 4 quarters	Revenue: $1.774B FY2026-Q2; GAAP. Published target: Revenue >= $1.425B per quarter next 4 quarters. Target period is not explicitly aligned with this observation. Source published Aug 6, 20261,774,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: feab9039-cf2a-4cbf-8ed8-75f32ab32229. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$0.65

$0.53 → $0.65 · observed estimates

FY2027 revenue$7.55B

$6.89B → $7.55B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$0.53	$6,885,762,600	20 / 19
2026-07-25	$0.53	$6,885,762,600	20 / 19
2026-07-26	$0.53	$6,885,762,600	20 / 19
2026-07-27	$0.53	$6,885,762,600	20 / 19
2026-07-28	$0.53	$6,885,762,600	20 / 19
2026-07-29	$0.54	$6,896,867,870	20 / 19
2026-07-30	$0.54	$6,896,867,870	20 / 19
2026-07-31	$0.54	$6,896,867,868	12 / 14
2026-08-01	$0.54	$6,896,867,868	12 / 14
2026-08-02	$0.54	$6,896,867,870	20 / 19
2026-08-03	$0.54	$6,896,867,868	12 / 14
2026-08-04	$0.54	$6,896,867,868	12 / 14
2026-08-05	$0.54	$6,896,867,868	12 / 14
2026-08-06	$0.54	$6,896,867,870	20 / 19
2026-08-08	$0.56	$7,238,343,920	19 / 19
2026-08-09	$0.56	$7,238,343,920	19 / 19
2026-08-10	$0.56	$7,238,343,920	19 / 19
2026-08-12	$0.61	$7,496,916,420	20 / 19
2026-08-13	$0.54	$6,896,867,868	12 / 14
2026-08-14	$0.54	$6,896,867,868	12 / 14
2026-08-15	$0.54	$6,896,867,868	12 / 14
2026-08-16	$0.54	$6,896,867,868	12 / 14
2026-08-17	$0.54	$6,896,867,868	12 / 14
2026-08-18	$0.54	$6,896,867,868	12 / 14
2026-08-19	$0.54	$6,896,867,868	12 / 14
2026-08-20	$0.61	$7,464,667,695	12 / 14
2026-08-21	$0.61	$7,464,667,695	12 / 14
2026-08-22	$0.61	$7,464,667,695	12 / 14
2026-08-23	$0.61	$7,464,667,695	12 / 14
2026-08-24	$0.61	$7,464,667,695	12 / 14
2026-08-25	$0.61	$7,464,667,695	12 / 14
2026-08-26	$0.61	$7,464,667,695	12 / 14
2026-08-27	$0.61	$7,464,667,695	12 / 14
2026-08-28	$0.61	$7,464,667,695	12 / 14
2026-08-29	$0.61	$7,464,667,695	12 / 14
2026-08-30	$0.61	$7,464,667,695	12 / 14
2026-08-31	$0.61	$7,464,667,695	12 / 14
2026-09-01	$0.61	$7,464,667,695	12 / 14
2026-09-02	$0.61	$7,464,667,695	12 / 14
2026-09-03	$0.61	$7,464,667,695	12 / 14
2026-09-04	$0.61	$7,464,667,695	12 / 14
2026-09-05	$0.61	$7,464,667,695	12 / 14
2026-09-06	$0.61	$7,464,667,695	12 / 14
2026-09-07	$0.61	$7,464,667,695	12 / 14
2026-09-08	$0.61	$7,464,667,695	12 / 14
2026-09-09	$0.61	$7,464,667,695	12 / 14
2026-09-10	$0.62	$7,472,175,411	12 / 14
2026-09-11	$0.62	$7,472,175,411	12 / 14
2026-09-12	$0.62	$7,472,175,411	12 / 14
2026-09-13	$0.62	$7,472,175,411	12 / 14
2026-09-14	$0.62	$7,472,175,411	12 / 14
2026-09-15	$0.62	$7,472,175,411	12 / 14
2026-09-16	$0.62	$7,472,175,411	12 / 14
2026-09-17	$0.62	$7,472,175,411	12 / 14
2026-09-18	$0.62	$7,472,175,411	12 / 14
2026-09-19	$0.62	$7,472,175,411	12 / 14
2026-09-20	$0.62	$7,472,175,411	12 / 14
2026-09-21	$0.62	$7,472,175,411	12 / 14
2026-09-22	$0.62	$7,472,175,411	12 / 14
2026-09-23	$0.62	$7,472,175,411	12 / 14
2026-09-24	$0.62	$7,482,385,937	12 / 14
2026-09-25	$0.62	$7,482,385,937	12 / 14
2026-09-26	$0.62	$7,482,385,937	12 / 14
2026-09-27	$0.62	$7,482,385,937	12 / 14
2026-09-28	$0.62	$7,482,385,937	12 / 14
2026-09-29	$0.62	$7,482,385,937	12 / 14
2026-09-30	$0.62	$7,482,385,937	12 / 14
2026-10-01	$0.62	$7,482,385,937	12 / 14
2026-10-02	$0.62	$7,482,385,937	12 / 14
2026-10-03	$0.62	$7,482,385,937	12 / 14
2026-10-04	$0.62	$7,484,263,639	12 / 14
2026-10-05	$0.62	$7,484,263,639	12 / 14
2026-10-06	$0.62	$7,536,575,879	12 / 14
2026-10-07	$0.63	$7,536,723,505	12 / 14
2026-10-08	$0.64	$7,541,212,979	12 / 14
2026-10-09	$0.64	$7,542,791,926	12 / 14
2026-10-10	$0.64	$7,542,791,926	12 / 14
2026-10-11	$0.64	$7,545,003,084	12 / 14
2026-10-12	$0.64	$7,545,003,084	12 / 14
2026-10-13	$0.64	$7,545,003,084	12 / 14
2026-10-14	$0.64	$7,545,003,084	12 / 14
2026-10-15	$0.64	$7,545,003,084	12 / 14
2026-10-16	$0.65	$7,545,743,400	12 / 14
2026-10-17	$0.65	$7,545,743,400	12 / 14
2026-10-18	$0.65	$7,545,743,400	12 / 14
2026-10-19	$0.65	$7,545,743,400	12 / 14
2026-10-20	$0.65	$7,545,743,400	12 / 14
2026-10-21	$0.65	$7,545,743,400	12 / 14
2026-10-22	$0.65	$7,545,743,400	12 / 14
2026-10-23	$0.65	$7,545,743,400	12 / 14
2026-10-24	$0.65	$7,545,743,400	12 / 14

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	6	14	2
2026-06-01	5	12	2
2026-07-01	6	13	3
2026-08-01	7	12	3
2026-09-01	7	12	3
2026-10-01	7	15	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 7 Buy / Strong Buy · 15 Hold · 2 Sell / Strong Sell

2 upgrades1 downgrades3 maintains

Recent actions · Sep 25–Oct 24 · 6 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Truist FinancialOct 7 · prior Aug 7

$28.00 → $30.00+7.1%

Wells FargoOct 6 · prior Sep 9

$23.00 → $30.00+30.4%

BMO CapitalOct 6 · prior Jul 13

$35.00 → $30.25-13.6%

$0$19.25$38.50

2 raises · 1 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

EPS turns positive and growsDirect metric needs a verified mapping
Gross margin holds near 13-15%Gross margin: 14.04%
Operating income improves toward break-evenOperating income: $1M
Revenue grows beyond $1.4 billion per quarterRevenue: $1.774B

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.7%Typical daily move · historical

Downside history

-40.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

RXO, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This investment represents a turnaround story with a focus on improving profitability and growth. The current thesis state is cautious, as recent performance has been weak and the company is still loss-making.

What's priced into RXO, Inc.

The market appears to have priced in a low level of expectations, as RXO is seen as cheap compared to its peers. However, there is a notable expectations gap, indicating that investors are not anticipating significant improvements in performance in the near term.

What the fundamentals likely do

Management is on track with its priorities, showing some progress in volume growth and profitability. However, recent financial performance has been weak, and there is an elevated risk of missing guidance again, which could impact future results.

What RXO, Inc. hinges on

The long-term thesis hinges on RXO's ability to maintain momentum in its Brokerage segment and expand its complementary services. Additionally, the performance of sector bellwethers like ODFL, XPO, and KNX will be crucial in determining RXO's trajectory.